Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,943,728
+$2,049,026 QoQ
Shares Held
62,778
+10.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#855
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $107,151,979 across 12 Drug Manufacturers - General names. JNJ ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,510 | $42,591,762 | |
| 2 | ABBV |
AbbVie Inc.
|
78,550 | $19,766,322 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
62,778 | $15,943,728 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,265 | $7,358,552 | |
| 5 | AMGN |
Amgen Inc
|
13,902 | $5,034,192 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
72,038 | $4,150,829 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,870 | $4,026,455 | |
| 8 | PFE |
Pfizer Inc
|
148,377 | $3,572,917 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,943,728 | 62,778 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,894,702 | 56,843 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,119,009 | 53,728 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,606,053 | 51,807 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,262,193 | 47,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,977,733 | 48,105 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,767,637 | 46,796 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,672,226 | 59,683 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,341,297 | 43,386 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,925,874 | 43,782 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,867,406 | 43,814 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,147,523 | 45,891 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,366,798 | 44,507 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $7,065,830 | 45,586 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,225,161 | 40,901 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,676,033 | 40,867 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $4,615,970 | 26,004 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,070,795 | 22,969 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,548,676 | 20,744 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,255,355 | 20,157 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,314,841 | 32,262 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,740,840 | 28,846 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $4,218,098 | 26,802 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $3,503,741 | 23,534 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $2,497,588 | 17,760 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,062,145 | 30,978 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||